4.3% DEXTROSE SALINE 500ML

4.3% Dextrose Saline is a combined intravenous infusion solution formulated to provide both energy and electrolyte support for patients requiring parenteral therapy. Manufactured by Dana Pharmaceuticals Limited in Nigeria, this product is designed for medical use under professional supervision and is available exclusively by prescription.

Product Overview

Product Name: 4.3% Dextrose Saline (500 mL)

Active Ingredients: Glucose (as Dextrose Monohydrate), Sodium Chloride

Concentration: Dextrose 4.3% w/v; Sodium Chloride 0.18% w/v

Dosage Form: Solution for infusion

Route of Administration: Intravenous (IV)

Pack Size: 500 mL (Viaflo pouch)

ATC Code: B05BB02

Product Category: Drugs

Marketing Category: Prescription-only Medicine (POM)

Product Description: Intravenous Infusion

Regulatory and Manufacturing Information

Applicant Name: Dana Pharmaceuticals Limited

NRN: 04-1215

Status: Active

Approval Date: October 28, 2021

Manufacturer: Dana Pharmaceuticals Limited

Manufacturer Country: Nigeria

Composition

Each 100 mL of solution contains:

Dextrose Monohydrate BP: 4.3 g (w/v)

Sodium Chloride: 0.18 g (w/v)

Water for Injection: Quantity sufficient to 100 mL

Clinical Uses

4.3% Dextrose Saline is used in clinical settings for several purposes, including:

Fluid and electrolyte replenishment: For patients unable to take oral fluids.

Correction of mild dehydration and electrolyte imbalance

Provision of carbohydrates: Supplies energy in the form of glucose for patients with limited oral intake.

Product Description

This solution is supplied in a 500 mL Viaflo pouch, ensuring sterility and ease of use in hospital and clinical environments. The infusion is clear and suitable for direct administration into the bloodstream.